Epidemiology and clinical features of COVID-19: A review of current literature

Juan A Siordia Jr, Juan A Siordia Jr

Abstract

Coronavirus disease 2019 is a pandemic influencing the first half of the year 2020. The virus has rapidly spread to many countries. Studies are rapidly published to share information regarding epidemiology, clinical and diagnostic patterns, and prognosis. The following review condenses the surge of information into an organized format.

Keywords: Coronavirus disease 2019; Diagnosis; Epidemiology; Pandemic; Severe acute respiratory disease.

Conflict of interest statement

Declaration of Competing Interest No conflict of interest to report.

Copyright © 2020 Elsevier B.V. All rights reserved.

Figures

Fig. 1
Fig. 1
Representation of COVID-19 Clinical and Transmission Periods.
Fig. 2
Fig. 2
A) Coronal thin-section unenhanced CT image showing ground-glass opacities with a rounded morphology (arrows). B) Axial thin-section unenhanced CT scan showing diffuse bilateral confluent and patchy ground-glass (white arrows) and consolidative (black arrows) pulmonary opacities. Note the peripheral propensity.
Fig. 3
Fig. 3
COVID-19 Diagnostic and Risk-Stratification Algorithm.

References

    1. Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020
    1. Zhu N., Zhang D., Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020
    1. Fang J., Deng L., Zhang L., Cai Y., Cheung C.W., Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19) J. Gen. Intern. Med. 2020
    1. Paules C.I., Marston H.D., Fauci A.S. Coronavirus infections—more than just the common cold. JAMA. 2020
    1. World Health Organization . 2020. Coronavirus Disease 2019 (COVID-19) Situation Report – 36.
    1. Wu F., Zhao S., Yu B. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269.
    1. Lu R., Zhao Z., Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574.
    1. Qin P., Du E.Z., Luo W.T. Characteristics of the life cycle of porcine deltacoronavirus (PDCoV) in vitro: replication kinetics, cellular ultrastructure and virion morphology, and evidence of inducing autophagy. Viruses. 2019;11:455.
    1. Qinfen Z. The life cycle of SARS coronavirus in Vero E6 cells. J. Med. Virol. 2004;73(3):332–337.
    1. Li F. Structure, function, and evolution of coronavirus spike proteins. Ann. Rev. Virol. 2016;3:237–261.
    1. Zhou P., Yang X.L., Wang X.G. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020
    1. Turner A.J., Hiscox J.A., Hooper N.M. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol. Sci. 2004;25:291–294.
    1. Gupte M., Boustany-Kari C.M., Bharadwaj K. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008;295:781–788.
    1. Su Z., Wu Y. A multiscale and comparative model for receptor binding of 2019 novel coronavirus and the implications of its life cycle in host cells. BioRxiv. 2020
    1. World Health Organization . World Health Organization; 2020. Rational Use of Personal Protective Equipment for Coronavirus Disease (COVID-19): Interim Guidance.
    1. Liu Y., Ning Z., Chen Y. Aerodynamic characteristics and RNA concentration of SARS-CoV-2 aerosol in Wuhan hospitals during COVID-19 outbreak. BioRxiv. 2020
    1. Woelfel R., Corman V.M., Guggemos W. Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster. MedRxiv. 2020
    1. van Doremalen N., Bushmaker T., Morris D.H. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 2020
    1. Li Q., Guan X., Wu P. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 2020;382:1199–1207.
    1. Chan J.F., Yan S., Kok K.H. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523.
    1. Tindale L.C., Coombe M., Stockdale J.E. Transmission interval estimates suggest pre-symptomatic spread of COVID-19. MedRxiv. 2020
    1. Lauer S.A., Grantz K.H., Bi Q. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 2020
    1. Pung R., Chiew C.J., Young B.E. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 2020
    1. Guan W.J., Ni Z.Y., Hu Y. Clinical characteristics of 2019 novel coronavirus infection in China. N. Engl. J. Med. 2020
    1. He X., Lau EHY Wu P. Temporal dynamics in viral shedding and transmissibility of COVID-19. MedRxiv. 2020
    1. Burke R.M., Midgley C.M., Dratch A. Active monitoring of persons exposed to patients with confirmed COVID-19 – United States, January—February 2020. MMWR. 2020;69:245–246.
    1. Cheng V.C.C., Wong S.C., Chen J.H.K. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect. Control Hosp. Epidemiol. 2020
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020
    1. Nishiura H., Kobayashi T., Miyama T. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) Int. J. Infect. Dis. 2020
    1. Mizumoto K., Kagaya K., Zarebski A., Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance. 2020
    1. Ng O.T., Marimuthu K., Chia P.Y. SARS-CoV-2 infection among travelers returning from Wuhan, China. N. Engl. J. Med. 2020
    1. Bai Y., Yao L., Wei T. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020
    1. Rothe C., Schunk M., Sothmann P. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 2020;382:970–971.
    1. Zou L., Ruan F., Huang M. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020;382:1177–1179.
    1. Li R., Pei S., Chen B. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2) Science. 2020
    1. Ai T., Yang Z., Hou H. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020
    1. Fang Y., Zhang H., Xie J. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiol. 2020
    1. Wang L., Gao Y.H., Lou L.L., Zhang G.J. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China. Eur. Resp. J. 2020
    1. Lo I.L., Lio C.F., Cheong H.H. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau. Int. J. Biol. Sci. 2020;16:1698–1707.
    1. Liu Y., Yan L.M., Wan L. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect. Dis. 2020
    1. Chinese Municipal Health Commission . 2020. The Management of 2019 Novel Coronavirus Infected Pneumonia: Interim Guidance.
    1. Yang J., Zheng Y., Gou X. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int. J. Infect. Dis. 2020
    1. Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on analysis of data of 150 patients from Wuhan, China. Intens. Care Med. Exp. 2020
    1. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020
    1. Ma C., Gu J., Hou P. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. MedRxiv. 2020
    1. Diaz J.H. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J. Travel Med. 2020
    1. Kuster G.M., Pfister O., Burkard T. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur. Heart J. 2020
    1. Sun M.L., Yang J.M., Sun Y.P., Su G.H. Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:e014.
    1. Thomson G. COVID-19: social distancing, ACE2 receptors, protease inhibitors and beyond? Int. J. Clin. Pract. 2020
    1. Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020
    1. Chung M., Bernheim A., Mei X. CT imaging features of 2019 novel coronavirus (2019-nCoV) Radiology. 2020;295:202–207.
    1. Bernheim A., Mei X., Huang M. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020
    1. Ai J.W., Chen J.W., Wang Y. The cross-sectional study of hospitalized coronavirus disease 2019 patients in Xiangyang, Hubei province. MedRxiv. 2020
    1. Chen X., Zheng F., Qing Y. Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study. MedRxiv. 2020
    1. Lin D., Liu L., Zhang M., Hu Y. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients. Sci. China Life Sci. 2020
    1. Xing Q., Li G., Xing Y. Precautions are needed for COVID-19 patients with coinfection of common respiratory pathogens. Lancet. 2020
    1. Bai T., Tu S., Wei Y. Clinical and laboratory factors predicting the prognosis of patients with COVID-19: an analysis of 127 patients in Wuhan, China. Lancet. 2020
    1. Li Q., Ding X., Xia G. A simple laboratory parameter facilitates early identification of COVID-19 patients. MedRxiv. 2020
    1. Driggin E., Madhavan M.V., Bikdeli B. Cardiovascular considerations for patients, health care works, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J. Am. Coll. Cardiol. 2020
    1. Corman V.M., Landt O., Kaiser M. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eur. Surveill. 2020;25(3)
    1. Xie X., Zhong Z., Zhao W., Zheng C., Wang F., Liu J. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. 2020
    1. General Office of National Health Committee . 2020. Office of State Administration of Traditional Chinese Medicine. Notice on the Issuance of a Program for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infected Pneumonia (Trial Fifth Edition)
    1. General Office of National Health Committee . 2020. Office of State Administration of Traditional Chinese Medicine. Notice on the Issuance of a Program for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infected Pneumonia (Trial Sixth Edition)
    1. Yoon S.H., Lee K.H., Kim J.Y. Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea. Korean J. Radiol. 2020;21(4):494–500.
    1. Ng M.Y., Lee E.Y.P., Yang J. Imaging profile of the COVID-19 infection: radiologic findings and literature review. Radiol. Cardiothorac. Imag. 2020
    1. Wang S., Kang B., Ma J., Zeng X., Xiao M., Guo J. A deep algorithm using CT images to screen for Corona Virus Disease (COVID-19) MedRxiv. 2020
    1. Gozes O., Frid-Adar M., Greenspan H., Browning P.D., Bernheim A., Siegel E. Rapid AI development cycle for the coronavirus (COVID-19) pandemic: initial results for automated detection and patient monitoring using deep learning CT imaging analysis. ArXiv. 2020
    1. Zhao W., Zhong Z., Xie X., Yu Q., Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. Am. J. Roentgenol. 2020;214:1–6.
    1. Bai H., Hsieh B., Xiong Z. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020
    1. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020
    1. Liu Y., Sun W., Li J. Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019. MedRxiv. 2020
    1. Tan Z.C., Fu L.H., Wang D.D., Hong K. Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:e005.
    1. Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020
    1. Guo T., Fan Y., Chen M. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020
    1. Chen C., Chen C., Yan J.T., Zhou N., Zhao J.P., Wang D.W. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:e008.
    1. Wu C., Hu X., Song J. Heart injury signs are associated with higher and earlier mortality in coronavirus disease 2019 (COVID-19) MedRxiv. 2020
    1. Zhou B., She J., Wang Y., Ma X. The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease. Lancet. 2020
    1. Lippi G., Lavie C.J., Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog. Cardiovasc. Dis. 2020
    1. Yang X.H., Sun R.H., Chen D.C. Diagnosis and treatment of COVID-19: acute kidney injury cannot be ignored. Zhoughua Yi Xue Za Zhi. 2020;100:e017.
    1. Xu D., Zhang H., Gong H.Y. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Preprints. 2020
    1. Riou J., Hauser A., Counotte M.J., Althaus C.L. Adjusted age-specific case fatality ratio during the COVID-19 epidemic in Hubei, China, January and February 2020. MedRxiv. 2020
    1. Yan L., Zhang H.T., Xiao Y. Prediction of criticality in patients with severe Covid-19 infection using three clinical features: a machine learning-based prognostic model with clinical data in Wuhan. MedRxiv. 2020
    1. Yan L., Zhang H.T., Goncalves J. A machine learning-based model for survival prediction in patients with severe COVID-19 infection. MedRxiv. 2020
    1. Tan L., Wang Q., Zhang D. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. MedRxiv. 2020
    1. Chen X., Ling J., Mo P. Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients. MedRxiv. 2020

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere